Source comparison
BPC-157 for Frozen Shoulder Research vs Standard Treatments
BPC-157 (research models) Collagen synthesis regulation, angiogenesis, MMP-2 upregulation 5–14 days in animal models Reduced 50% in controlled trials Targets fibrosis directly; human trial data needed Corticosteroid injection Suppress synovial inflammation via
This comparison does not assign a generated winner or score.
- BPC-157 (research models)
- Collagen synthesis regulation, angiogenesis, MMP-2 upregulation
- 5–14 days in animal models
- Reduced 50% in controlled trials
- Targets fibrosis directly; human trial data needed
- Corticosteroid injection
- Suppress synovial inflammation via COX-2 inhibition
- 3–7 days (pain), no structural change
- No reduction
- Effective for pain, does not reverse capsular fibrosis
- Physical therapy
- Mechanical capsular stretching, neuromuscular retraining
- 8–24 weeks
- Minimal direct effect
- Gold standard but slow; depends on patient compliance
- Hyaluronic acid injection
- Lubrication, mild anti-inflammatory
- 2–4 weeks
- No proven reduction
- Symptom relief only; limited evidence in adhesive capsulitis
- Capsular release surgery
- Surgical division of contracted capsule
- Immediate post-op, 6–12 weeks full recovery
- Mechanical division, not remodeling
- Fastest structural intervention; invasive with surgical risk
- BPC-157 stands apart because it's the only intervention in this table with demonstrated histological capsular normalization in controlled models. Corticosteroids manage inflammation. Physical therapy stretches existing tissue. Surgery cuts the problem away. BPC-157 for frozen shoulder research shows the capsule remodeling itself. Thinner, more organized collagen, restored vascular density. Which is why labs are pursuing it despite the lack of human clinical trials.